Clinical trial
The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke
NCT02580838 is registered in ClinicalTrials.gov with National Cheng-Kung University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke
- Lead sponsor
- National Cheng-Kung University Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- August 31, 2015
- Completion date
- September 30, 2025
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.